Latest journal
All journals![EMJ Hematology 9 [Supplement 5] 2021 feature image](https://emj.emg-health.com/wp-content/uploads/sites/2/2021/11/EMJ-Hematology-9-Supplement-5-2021-feature-image-940x563.png)
November 2021
In this interview, two experts in the field of acute myeloid leukaemia (AML), Jean-Baptiste Micol, University of Paris-Saclay, France, and Thomas Cluzeau, University Hospital of Nice, France, share their views and debate the current landscape of real-world data in AML research and treatment.
Latest articles
All articles![EMJ Oncology 9 [Supplement 8] 2021 Feature Image](https://emj.emg-health.com/wp-content/uploads/sites/2/2021/11/EMJ-Oncology-9-Supplement-8-2021-Feature-Image-940x563.jpg)
Be the first to hear about new developments in #Oncology. Subscribe today, and don't forget to follow us on twitter… twitter.com/i/web/status/1…
Posted 03 December
Discover all of EMJ #Hematology articles in just one click! Have a read.. hubs.la/H0_G27-0 and follow us on… twitter.com/i/web/status/1…
Posted 02 December
Multiple myeloma is a condition that affects predominantly the older population. There are now various approved che… twitter.com/i/web/status/1…
Posted 01 December
Is allogeneic stem cell transplantation a good option for paroxysmal nocturnal haemoglobinuria? Find out here:… twitter.com/i/web/status/1…
Posted 30 November
Acute myeloid leukaemia (AML) is a highly heterogeneous disorder and is characterised by the proliferation of poorl… twitter.com/i/web/status/1…
Posted 29 November
